2 results match your criteria: "From the National Hospital of Neurology and Neurosurgery[Affiliation]"
Teaching NeuroImages: Hypertrophic polyneuropathy.
Neurology
August 2020
From the National Hospital of Neurology and Neurosurgery, Queen Square, Holborn, London, UK.
Thromboembolic risk with IVIg: Incidence and risk factors in patients with inflammatory neuropathy.
Neurology
February 2020
From the National Hospital of Neurology and Neurosurgery (J.S., C.E., S.S.-G., M.P.L., A.C.); MRC Centre for Neuromuscular Diseases, Department of Neuromuscular Diseases (M.K., A.R., H.M., M.M.R.), UCL Institute of Neurology; Department of Cardiology (R.B.), University College London Hospital; and Department of Neuroimmunology (M.P.L.), Institute of Neurology, London, UK.
Our objective was to evaluate whether IV immunoglobulin (IVIg) increases the risk of thromboembolic events in neurology outpatients with inflammatory neuropathies, as there is conflicting evidence supporting this hypothesis, mainly from non-neurologic cohorts. We investigated this question over 30 months in our cohort of patients with inflammatory neuropathies receiving regular IVIg and found a greater incidence of arterial and venous thromboembolic events than population-based rates determined by hospital admissions data. Vascular risk factors were more common in the event group but there were no IVIg administration factors that contributed to the risk.
View Article and Find Full Text PDF